Literature DB >> 19669813

Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities.

Takakazu Kawamata1, Kosaku Amano, Yasuo Aihara, Osami Kubo, Tomokatsu Hori.   

Abstract

Although many authors have described treatment strategies for craniopharyngiomas, the optimal treatment of craniopharyngiomas remains controversial. This study aimed to define an adequate surgical strategy for craniopharyngiomas by reviewing the long-term functional performance of patients treated by current and past treatment modalities. Fifty-five patients with longer than 5 years of follow-up were selected for the present long-term study. The duration of follow-up ranged from 5.5 to 33 years (median, 14.8 years). There were 28 adult patients (14 males; median age, 44.4 years) and 27 children younger than 16 years of age (15 males; median age, 8.1 years). The patients were divided into the following treatment groups: single surgery (group A; n=14 multiple surgeries (group B; n=8), surgery or surgeries followed by radiotherapy (group C; n=23), surgery or surgeries (partial removal) followed by radiotherapy + additional treatments (multiple surgeries and/or re-irradiation; group D; n=10). In addition to the routine assessments of neurological, endocrine, and visual outcomes, the level of daily functioning was analyzed using the Karnofsky Performance Scale (KPS). Statistical analysis of relationship between KPS score and treatment mode demonstrated that group D had a significantly lower KPS score (F=5.82, p=0.0017). Furthermore, mortality, cognitive function, and visual function were significantly better in groups A, B, and C than in group D. Multiple regression analysis demonstrated that cognitive dysfunction, visual disturbance, and treatment mode were independent covariates that significantly affected postoperative KPS score. Adequate primary treatment for craniopharyngiomas is important to avoid subsequent multiple treatments. Craniopharyngiomas should be removed surgically as far as possible but without further deteriorating cognitive and visual functions, either as total resection or subtotal resection with a small remnant that is controllable by radiation therapy.

Entities:  

Mesh:

Year:  2010        PMID: 19669813     DOI: 10.1007/s10143-009-0220-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  44 in total

1.  Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience.

Authors:  Juliette Hukin; Paul Steinbok; Lucie Lafay-Cousin; Glenda Hendson; Douglas Strother; Claude Mercier; Yvan Samson; William Howes; Eric Bouffet
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

2.  Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.

Authors:  C J de Vile; D B Grant; R D Hayward; B E Kendall; B G Neville; R Stanhope
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

3.  Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources.

Authors:  J Voges; V Sturm; R Lehrke; H Treuer; C Gauss; F Berthold
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

4.  Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas.

Authors:  Jenö Julow; Erik-Olof Backlund; Ferenc Lányi; Márta Hajda; Katalin Bálint; István Nyáry; György T Szeifert
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

5.  Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.

Authors:  M G Yaşargil; M Curcic; M Kis; G Siegenthaler; P J Teddy; P Roth
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

Review 6.  Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation.

Authors:  W F Regine; M Mohiuddin; S Kramer
Journal:  Radiother Oncol       Date:  1993-04       Impact factor: 6.280

7.  Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases.

Authors:  Lucie Lafay-Cousin; Ute Bartels; Charles Raybaud; Abhaya V Kulkarni; Sharon Guger; Annie Huang; Eric Bouffet
Journal:  J Neurosurg       Date:  2007-10       Impact factor: 5.115

8.  Microsurgery of the hypothalamus with special reference to craniopharyngioma.

Authors:  L Symon
Journal:  Neurosurg Rev       Date:  1983       Impact factor: 3.042

9.  Long term results in the management of craniopharyngiomas.

Authors:  F G McMurry; R W Hardy; D F Dohn; E Sadar; W J Gardner
Journal:  Neurosurgery       Date:  1977 Nov-Dec       Impact factor: 4.654

10.  Surgical management of craniopharyngiomas. A review of 74 cases.

Authors:  D S Baskin; C B Wilson
Journal:  J Neurosurg       Date:  1986-07       Impact factor: 5.115

View more
  8 in total

1.  Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients.

Authors:  Philipp Kickingereder; Mohammad Maarouf; Faycal El Majdoub; Manuel Fuetsch; Ralph Lehrke; Jochen Wirths; Klaus Luyken; Klaus Schomaecker; Harald Treuer; Juergen Voges; Volker Sturm
Journal:  J Neurooncol       Date:  2012-06-21       Impact factor: 4.130

2.  Outcomes of Gamma Knife surgery for craniopharyngiomas.

Authors:  Zhiyuan Xu; Chun-Po Yen; David Schlesinger; Jason Sheehan
Journal:  J Neurooncol       Date:  2010-12-14       Impact factor: 4.130

3.  Reirradiation for recurrent craniopharyngioma.

Authors:  Sarah J Foran; Normand Laperriere; Kim Edelstein; Laura Janzen; Tony Tadic; Vijay Ramaswamy; David Shultz; Fred Gentili; Eric Bouffet; Derek S Tsang
Journal:  Adv Radiat Oncol       Date:  2020-08-07

4.  Predictive factors for vision recovery after optic nerve decompression for chronic compressive neuropathy: systematic review and meta-analysis.

Authors:  Andrew P Carlson; Martina Stippler; Orrin Myers
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-26

5.  Should adjuvant radiotherapy be recommended for pediatric craniopharyngiomas?

Authors:  Ravi Dadlani; Nandita Ghosal; Alangar Sathya Hegde
Journal:  J Korean Neurosurg Soc       Date:  2014-01-31

Review 6.  Mortality and morbidity in adult craniopharyngioma.

Authors:  Eva Marie Erfurth; Helene Holmer; Sigridur Bara Fjalldal
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 7.  Endocrine Disorder in Patients With Craniopharyngioma.

Authors:  Zihao Zhou; Sheng Zhang; Fangqi Hu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

8.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.